{"title":"噻唑烷-4-羧酸衍生物对新型流感神经氨酸酶抑制活性的验证","authors":"Aakanksha Yadav, N. Jain, Anita k","doi":"10.2174/2211544712666230406123325","DOIUrl":null,"url":null,"abstract":"\n\nNeuraminidase enzymes are a large family found in a range of organisms. The best-known neuraminidase is viral neuraminidase, a drug target for the prevention of the spread of influenza infection. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.\n\n\n\nStudied on a 28 series compound and came with the most potent drug towards Influenza\n\n\n\nThiazolidine derivatives have been synthesized and explored previously, and further compounds have been designed on the basis of leading compounds. This research aimed to validate those previously synthesized compounds and a new series of compounds.\n\n\n\nTo make the most potent drug with enhanced biological activity.\n\n\n\nA series of 28 compounds of thiazolidine-4-carboxylic acid derivatives were studied and evaluated for their ability to inhibit the neuraminidase (NA) of the influenza A virus. Twenty-eight compounds were differentiated into a training set of 21 compounds and a test set of 07 compounds.\n\n\n\nA series of 28 compounds of thiazolidine-4-carboxylic acid derivatives was studied and evaluated for their ability to inhibit neuraminidase (NA) of influenza A virus. Compound was drawn on ChemSketch and further evaluated.\n\n\n\nThe validated compounds demonstrated moderate inhibitory activity against influenza A neuraminidase. The most potent compound was acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34). S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine is an S-substituted N-acetyl-L-cysteine in which the S-substituent is specified as 5-acetamido-2-hydroxyphenyl. It acts as a drug metabolite, a human urinary metabolite, and a rat metabolite. It is a member of acetamides, an organic sulphide, a member of phenols and an S-substituted N-acetyl-L-cysteine. It derives from “paracetamol”.\n\n\n\nThe most potent compound is Acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34) S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine is an S-substituted N-acetyl-L-cysteine in which the S-substituent is specified as 5-acetamido-2-hydroxyphenyl.\n\n\n\nValidation of inhibitory activity of thiazolidine-4-carboxylic acid derivatives as novel influenza NA shows drug discovery of a more potent and reliable drug for the influenza virus.\n\n\n\nAll the studies and evaluation carried out in this paper is only to get the most potent compound or drug with enhanced biological activity.\n\n\n\nAs to it, 10 predicted compounds also being proposed in the given paper\n","PeriodicalId":10862,"journal":{"name":"Current Catalysis","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validation of Inhibitory Activity of Thiazolidine-4-carboxylic Acid Derivatives against Novel Influenza Neuraminidase Enzyme\",\"authors\":\"Aakanksha Yadav, N. Jain, Anita k\",\"doi\":\"10.2174/2211544712666230406123325\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nNeuraminidase enzymes are a large family found in a range of organisms. The best-known neuraminidase is viral neuraminidase, a drug target for the prevention of the spread of influenza infection. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.\\n\\n\\n\\nStudied on a 28 series compound and came with the most potent drug towards Influenza\\n\\n\\n\\nThiazolidine derivatives have been synthesized and explored previously, and further compounds have been designed on the basis of leading compounds. This research aimed to validate those previously synthesized compounds and a new series of compounds.\\n\\n\\n\\nTo make the most potent drug with enhanced biological activity.\\n\\n\\n\\nA series of 28 compounds of thiazolidine-4-carboxylic acid derivatives were studied and evaluated for their ability to inhibit the neuraminidase (NA) of the influenza A virus. Twenty-eight compounds were differentiated into a training set of 21 compounds and a test set of 07 compounds.\\n\\n\\n\\nA series of 28 compounds of thiazolidine-4-carboxylic acid derivatives was studied and evaluated for their ability to inhibit neuraminidase (NA) of influenza A virus. Compound was drawn on ChemSketch and further evaluated.\\n\\n\\n\\nThe validated compounds demonstrated moderate inhibitory activity against influenza A neuraminidase. The most potent compound was acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34). S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine is an S-substituted N-acetyl-L-cysteine in which the S-substituent is specified as 5-acetamido-2-hydroxyphenyl. It acts as a drug metabolite, a human urinary metabolite, and a rat metabolite. It is a member of acetamides, an organic sulphide, a member of phenols and an S-substituted N-acetyl-L-cysteine. It derives from “paracetamol”.\\n\\n\\n\\nThe most potent compound is Acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34) S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine is an S-substituted N-acetyl-L-cysteine in which the S-substituent is specified as 5-acetamido-2-hydroxyphenyl.\\n\\n\\n\\nValidation of inhibitory activity of thiazolidine-4-carboxylic acid derivatives as novel influenza NA shows drug discovery of a more potent and reliable drug for the influenza virus.\\n\\n\\n\\nAll the studies and evaluation carried out in this paper is only to get the most potent compound or drug with enhanced biological activity.\\n\\n\\n\\nAs to it, 10 predicted compounds also being proposed in the given paper\\n\",\"PeriodicalId\":10862,\"journal\":{\"name\":\"Current Catalysis\",\"volume\":\"7 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Catalysis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2211544712666230406123325\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Catalysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2211544712666230406123325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
神经氨酸酶是存在于多种生物体中的一个大家族。最著名的神经氨酸酶是病毒性神经氨酸酶,一种预防流感感染传播的药物靶点。病毒神经氨酸酶常被用作在流感病毒表面发现的抗原决定因子。对28系化合物进行了研究,并带来了对流感最有效的药物,噻唑烷衍生物已被合成和探索,并在主要化合物的基础上设计了进一步的化合物。本研究旨在验证这些先前合成的化合物和一系列新的化合物。制造出生物活性最强的药物。研究并评价了28种噻唑烷-4-羧酸衍生物对甲型流感病毒神经氨酸酶(NA)的抑制作用。28种化合物被分为21种化合物的训练集和07种化合物的测试集。研究并评价了28个噻唑烷-4-羧酸衍生物对甲型流感病毒神经氨酸酶(NA)的抑制作用。化合物在ChemSketch上绘制并进一步评价。经验证的化合物显示出对甲型流感神经氨酸酶的适度抑制活性。最有效的化合物是对乙酰氨基酚(C13H16N2O5S)(分子量:312.34)。S-(5-乙酰氨基-2-羟基苯基)- n -乙酰基- l-半胱氨酸是一种S取代的n -乙酰基- l-半胱氨酸,其中S取代基指定为5-乙酰氨基-2-羟基苯基。它可以作为药物代谢物、人类尿液代谢物和大鼠代谢物。它是乙酰胺、有机硫化物、酚类和s取代的n -乙酰- l-半胱氨酸的成员。它来源于“扑热息痛”。最有效的化合物是Acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34) S-(5-acetamido-2-hydroxyphenyl)- n -acetyl- l-半胱氨酸是一种S取代的n -acetyl- l-半胱氨酸,其中S取代基为5-acetamido-2-hydroxyphenyl。噻唑烷-4-羧酸衍生物作为新型流感NA的抑制活性验证表明发现了一种更有效和可靠的流感病毒药物。本文所进行的所有研究和评价只是为了获得最有效的具有增强生物活性的化合物或药物。对此,本文还提出了10种预测化合物
Validation of Inhibitory Activity of Thiazolidine-4-carboxylic Acid Derivatives against Novel Influenza Neuraminidase Enzyme
Neuraminidase enzymes are a large family found in a range of organisms. The best-known neuraminidase is viral neuraminidase, a drug target for the prevention of the spread of influenza infection. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.
Studied on a 28 series compound and came with the most potent drug towards Influenza
Thiazolidine derivatives have been synthesized and explored previously, and further compounds have been designed on the basis of leading compounds. This research aimed to validate those previously synthesized compounds and a new series of compounds.
To make the most potent drug with enhanced biological activity.
A series of 28 compounds of thiazolidine-4-carboxylic acid derivatives were studied and evaluated for their ability to inhibit the neuraminidase (NA) of the influenza A virus. Twenty-eight compounds were differentiated into a training set of 21 compounds and a test set of 07 compounds.
A series of 28 compounds of thiazolidine-4-carboxylic acid derivatives was studied and evaluated for their ability to inhibit neuraminidase (NA) of influenza A virus. Compound was drawn on ChemSketch and further evaluated.
The validated compounds demonstrated moderate inhibitory activity against influenza A neuraminidase. The most potent compound was acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34). S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine is an S-substituted N-acetyl-L-cysteine in which the S-substituent is specified as 5-acetamido-2-hydroxyphenyl. It acts as a drug metabolite, a human urinary metabolite, and a rat metabolite. It is a member of acetamides, an organic sulphide, a member of phenols and an S-substituted N-acetyl-L-cysteine. It derives from “paracetamol”.
The most potent compound is Acetaminophen mercapturate (C13H16N2O5S) (MW: 312.34) S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine is an S-substituted N-acetyl-L-cysteine in which the S-substituent is specified as 5-acetamido-2-hydroxyphenyl.
Validation of inhibitory activity of thiazolidine-4-carboxylic acid derivatives as novel influenza NA shows drug discovery of a more potent and reliable drug for the influenza virus.
All the studies and evaluation carried out in this paper is only to get the most potent compound or drug with enhanced biological activity.
As to it, 10 predicted compounds also being proposed in the given paper